Design of Liposomes Carrying HelixComplex Snail Mucus: Preliminary Studies |
| |
Authors: | Andrea Alogna,Valentina Gentili,Claudio Trapella,Supandeep Singh Hallan,Maddalena Sguizzato,Giovanni Strazzabosco,Mercedes Ferná ndez,Rita Cortesi,Roberta Rizzo,Daria Bortolotti |
| |
Affiliation: | 1.Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, I-44121 Ferrara, Italy; (V.G.); (C.T.); (S.S.H.); (M.S.); (G.S.); (M.F.); (R.R.); (D.B.);2.Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, 70 Eliporto Street, I-44121 Ferrara, Italy;3.Biotechnology Interuniversity Consortium (C.I.B.), Ferrara Section, University of Ferrara, I-44121 Ferrara, Italy |
| |
Abstract: | In recent decades liposomes have been used in different field thanks to their ability to act as a vehicle for a wide range of biomolecules, their great versatility and their easy production. The aim of this study was to evaluate liposomes as a vehicle for the actives present in the HelixComplex (HC) snail mucus for topical delivery. Liposomes composed of a mixture of phosphatidylcholine, cholesterol and octadecylamine were prepared with and without HC (empty liposomes) and their biological efficacy was tested by evaluating cell viability and migration. HC-loaded liposomes (LHC) were stable throughout 60 days of observation, and showed interesting effects on wound healing reconstitution. In particular, we observed that 25 µg/mL LHC were already able to induce a higher cell monolayer reconstitution in comparison to the untreated samples and HC treated samples after only 4 h (28% versus 10% and 7%, p = 0.03 and p= 0.003, respectively). The effect was more evident at 24 h in comparison with the untreated control (54% versus 21.2% and 41.6%, p = 0.006 and p = NS, respectively). These results represent a preliminary, but promising, novelty in the delivery strategy of the actives present in the HelixComplex mucus. |
| |
Keywords: | slime mucus HelixComplex liposomes MTT test drug delivery |
|
|